🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a multi-country, multi-center retrospective observational coh...
Status
Recruiting
Location
Investigational Site Number: 0560001
Start Date
2026-03-16
Trial ID
NCT07457580
Treatments Being Tested
The goal of this study is to determine how a drug class called glucagon-lik...
Status
Recruiting
Location
Vanderbilt University Medical Center
Start Date
2024-06-12
Trial ID
NCT06338553
Treatments Being Tested
The primary purpose of this study is to determine whether teplizumab (MGA03...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2009-09
Trial ID
NCT00920582
This is a randomized placebo controlled study to test whether a single 14 c...
Status
Completed
Location
University of California at San Francisco
Start Date
2006-09
Trial ID
NCT00378508
Treatments Being Tested
This is an observational, prospective cohort study designed to evaluate the...
Status
Recruiting
Location
Investigational Site Number: 8400003
Start Date
2026-03-19
Trial ID
NCT07360080
Treatments Being Tested
This is a phase II study to examine the clinical and immunological effects ...
Status
Terminated
Location
University of California San Francisco
Start Date
2002-05
Trial ID
NCT00806572
Treatments Being Tested
The purpose of this study is to assess the long term safety and efficacy in...
Status
Terminated
Location
Atlanta Diabetes Associates
Start Date
2009-02
Trial ID
NCT00870818
Treatments Being Tested
The purpose of this study is to assess the safety and pharmacokinetics (PK)...
Status
Active Not Recruiting
Location
UCSF Medical Center Site Number : 107
Start Date
2023-07-25
Trial ID
NCT05757713
Treatments Being Tested
The study will determine whether the anti-CD3 monoclonal antibody, teplizum...
Status
Completed
Location
University of California in San Francisco
Start Date
2010-08
Trial ID
NCT01030861
Treatments Being Tested
The purpose of this study is to determine whether teplizumab slows the loss...
Status
Completed
Location
Rady Children's Hospital-San Diego (Site 004)
Start Date
2019-04-05
Trial ID
NCT03875729
Treatments Being Tested